Keyword: GlaxoSmithKline (GSK)
Markets & Companies
15.07.2016
- As the reality, and increasingly the finality, of Britain’s June 23 vote to leave the European Union began to sink in, chemical and pharmaceutical producers across the country in...
News
17.06.2016
- GlaxoSmithKline’s head of vaccines, Moncef Slaoui, has announced he will leave the company in June 2017 after nearly three decades at the company. Since joining GSK in 1998, Slaoui...
News
17.05.2016
- A break-up of the UK’s largest pharmaceutical company, GlaxoSmithKline (GSK) is not under consideration at the moment, GSK Chairman Phillip Hampton told the company’s annual...
News
01.04.2016
- Glaxo SmithKline has announced it will waive patent protection for new medicines in the world’s poorest countries, such as Afghanistan, Rwanda and Cambodia, allowing cheaper...
News
22.03.2016
- Britain’s largest pharmaceutical company, Glaxo SmithKline (GSK), has formed a strategic collaboration with German biotechnology firm Miltenyi Biotec to develop cell and gene...
News
18.03.2016
- It’s official. Andrew Witty, CEO of Britain’s largest drugmaker, Glaxo SmithKline (GSK), has announced he will retire in March 2017 after nearly a decade at the helm. In a...
News
16.03.2016
- AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...
News
15.03.2016
- British drugmaker Glaxo SmithKline (GSK) has pulled out of a five-year deal with US biotechnology company Five Prime to develop experimental cancer drug FP-1039. Buried in Five...
